Antibody-Drug Conjugates: A Promising Novel Therapy for the Treatment of Ovarian Cancer

Antibody-drug conjugates (ADCs) represent a novel and promising therapeutic strategy for the treatment of cancer patients. ADCs target antigens highly expressed on the membrane surface of tumor cells to selectively deliver a cytotoxic drug. Ovarian tumors differentially express tumor-specific antige...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzano, Aranzazu, Ocaña, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464539/
https://www.ncbi.nlm.nih.gov/pubmed/32784819
http://dx.doi.org/10.3390/cancers12082223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464539/
https://www.ncbi.nlm.nih.gov/pubmed/32784819
http://dx.doi.org/10.3390/cancers12082223

Ejemplares similares